KEY TAKEAWAY POINTS
- There is extensive evidence in literature supporting the efficacy of selective laser trabeculoplasty in the treatment of various glaucoma types, including primary open angle glaucoma, pseudoexfoliative glaucoma, pigmentary glaucoma and normal tension glaucoma.
- The LiGHT trial established that the efficacy of first-line SLT is comparable to first-line topical medication, with some potential advantages.
- DSLT is a new treatment modality aiming to simplify the SLT procedure, offering automated, non- contact, translimbal laser application.
- The GLAUrious trial shows that DSLT can reduce IOP in a clinically meaningful manner. The level of IOP reduction achieved is not dependent on glaucoma subtype or angle pigmentation.